Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus;Effekt af lisinopril pa progression af retinopati og mikroalbuminuri hos normotensive personer med insulinafhaengig diabetes mellitus

Ugeskrift for Laeger

Volumn 161, Issue 7, 1999, Pages 949-952

  Sjølie, Anne Katrin ^a,b   Chaturvedi, Nish ^a   Fuller, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; LISINOPRIL; PLACEBO; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; MULTICENTER STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; AGED; ALBUMINURIA; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0033557793     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Moss SE, Klein R, Klein BEK. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81: 1158-62.
2. Wang S-L, Head J, Stevens L, Fuller JH, WHO Multinational Study Group. Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1996; 9: 305-12.
3. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti G-C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992; 41: 836-9.
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, and the Collaborative Study Group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993: 329: 1456-62.
5. The Microalbumin Captopril Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996; 39: 587-93.
6. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-9.
7. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL, The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-6.
8. Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. Ophthalmology 1997; 104: 252-60.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
10. Larsen M, Hommel E, Parving HH, Lund-Andersen H. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol 1990; 228: 505-9.
11. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK, the EURODIAB IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 437-44.
12. Pedersen MM, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Med 1988; 5: 562-9.
13. Wiegmann TB, Herron KG, Chonko AM, MacDougall ML, Moore WV. Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes 1992; 41: 62-7.